COVID-19 Law and Policy Briefings, Series Two: Vaccine Distribution
dc.creator | Berman, Micah | |
dc.creator | Reiss, Dorit | |
dc.creator | Terry, Nicolas P. | |
dc.creator | Levin, Donna | |
dc.date.accessioned | 2022-02-18T15:18:48Z | |
dc.date.available | 2022-02-18T15:18:48Z | |
dc.date.issued | 2021-01-21 | |
dc.identifier.citation | This Week in Health Law, COVID-19 Law and Policy Briefings, Series Two: Vaccine Distribution, (January 21, 2021), https://mcdn.podbean.com/mf/web/ngjxrw/twihl_223.mp3. | |
dc.identifier.uri | http://hdl.handle.net/20.500.12613/7388 | |
dc.description | The COVID-19 Law and Policy Briefings, hosted in two series from March 2020 through July 2021, feature US and international public health law experts discussing the biggest legal issues arising from the COVID-19 pandemic. The briefings are produced by the George Consortium, co-sponsored by the Center for Health Policy and Law at Northeastern University School of Law, the Center for Public Health Law Research at Temple University Beasley School of Law, and the APHA Law Section. Visit Public Health Law Watch (http://bit.ly/COVIDLawBriefing) to watch episodes. All past briefings are also archived by The Week in Health Law podcast. | |
dc.description.abstract | Though COVID vaccine production is ramping up, the U.S. is lagging well behind schedule in distributing and administering available vaccines. Efforts at the state level are being further hampered by slapdash attempts at coordination and a growing resistance to receiving the vaccine among certain populations. What can employers, schools and governments legally do to encourage uptake? In the first COVID Law Briefing of 2021, we will analyze best practices and sound strategies to get vaccine distribution back on track. | |
dc.format.extent | 00:20:50 | |
dc.language | English | |
dc.language.iso | eng | |
dc.relation.ispartof | Center for Public Health Law Research | |
dc.relation.ispartof | COVID-19 Research | |
dc.relation.haspart | The Week in Health Law, Ep. 223 | |
dc.rights | All Rights Reserved | |
dc.subject | COVID-19 (Disease)--United States | |
dc.subject | COVID-19 Pandemic, 2020--United States | |
dc.subject | Public health laws | |
dc.subject | Vaccines--research | |
dc.subject | Drug development | |
dc.relation.youtube | https://youtu.be/aH7YIFml_og | |
dc.title | COVID-19 Law and Policy Briefings, Series Two: Vaccine Distribution | |
dc.type | Sound | |
dc.type.genre | Audio recording | |
dc.contributor.group | George Consortium | |
dc.contributor.group | Center for Health Policy and Law (Northeastern University School of Law) | |
dc.contributor.group | Center for Public Health Law Research (Temple University Beasley School of Law) | |
dc.contributor.group | APHA Law Section | |
dc.relation.doi | http://dx.doi.org/10.34944/dspace/7366 | |
dc.ada.note | For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu | |
dc.description.schoolcollege | Temple University. James E. Beasley School of Law | |
refterms.dateFOA | 2022-02-18T15:18:48Z |